chr7-152648677-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005431.2(XRCC2):c.808T>G(p.Phe270Val) variant causes a missense change. The variant allele was found at a frequency of 0.000359 in 1,608,224 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005431.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XRCC2 | NM_005431.2 | c.808T>G | p.Phe270Val | missense_variant | Exon 3 of 3 | ENST00000359321.2 | NP_005422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XRCC2 | ENST00000359321.2 | c.808T>G | p.Phe270Val | missense_variant | Exon 3 of 3 | 1 | NM_005431.2 | ENSP00000352271.1 | ||
XRCC2 | ENST00000495707.1 | n.830T>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
XRCC2 | ENST00000698506.1 | c.640T>G | p.Phe214Val | missense_variant | Exon 2 of 2 | ENSP00000513758.1 |
Frequencies
GnomAD3 genomes AF: 0.00190 AC: 289AN: 152172Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000527 AC: 129AN: 244722Hom.: 0 AF XY: 0.000339 AC XY: 45AN XY: 132798
GnomAD4 exome AF: 0.000198 AC: 289AN: 1455934Hom.: 0 Cov.: 31 AF XY: 0.000153 AC XY: 111AN XY: 724226
GnomAD4 genome AF: 0.00190 AC: 289AN: 152290Hom.: 2 Cov.: 32 AF XY: 0.00171 AC XY: 127AN XY: 74474
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Curator: Arleen D. Auerbach. Submitter to LOVD: Johan den Dunnen. -
- -
- -
not specified Benign:2
DNA sequence analysis of the XRCC2 gene demonstrated a sequence change, c.808T>G, in exon 3 that results in an amino acid change, p.Phe270Val. This sequence change does not appear to have been previously described in patients with XRCC2-related disorders and has been described in the gnomAD database with a low population frequency of 0.70% in African subpopulation (dbSNP rs145085742). The p.Phe270Val change affects a highly conserved amino acid residue located in a domain of the XRCC2 protein that is not known to be functional. The p.Phe270Val substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Phe270Val change remains unknown at this time. -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hereditary cancer-predisposing syndrome Benign:2
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Fanconi anemia complementation group U Benign:1
- -
XRCC2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at